F-group (family)
292.1.1.1 RIP
Ligands and drugs
484
Member domains
304
with ligand contacts (≤ 4 Å)
62.8% of members
288
with DrugDomain annotations
59.5% of members
230
with a DrugBank compound
47.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 292.1.1.1 belongs to X-group 292 RIP/Polo-box domain, which binds 9.6 ligand superclasses per 20 proteins, broader than 90% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 94 |
| DB00173 | ADE | Adenine | 34 |
| DB00131 | AMP | Adenosine phosphate | 7 |
| DB03464 | FMP | Formycin-5'-Monophosphate | 5 |
| DB02175 | MLA | Malonic acid | 4 |
| DB02377 | GUN | Guanine | 4 |
| DB02281 | FMC | Formycin | 3 |
| DB02701 | NCA | Nicotinamide | 3 |
| DB03419 | URA | Uracil | 3 |
| DB00640 | ADN | Adenosine | 2 |
| DB01960 | M7G | 7-methyl-7,8-dihydroguanosine-5'-diphosphate | 2 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 2 |
| DB02527 | CMP | Cyclic adenosine monophosphate | 2 |
| DB02716 | MGP | 7-methyl-guanosine-5'-triphosphate | 2 |
| DB04196 | PT1 | Pteroic acid | 2 |
| DB04357 | APT | Pteric acid | 2 |
| DB11336 | H35 | Kinetin | 2 |
| DB00125 | ARG | Arginine | 1 |
| DB00126 | ASC | Ascorbic acid | 1 |
| DB00130 | GLN | L-Glutamine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 98 |
| CL | CHLORIDE ION | 48 |
| ADE | ADENINE | 35 |
| ZNmetal | ZINC ION | 15 |
| NAmetal | SODIUM ION | 8 |
| AMP | ADENOSINE MONOPHOSPHATE | 7 |
| AZI | AZIDE ION | 5 |
| FMP | FORMYCIN-5'-MONOPHOSPHATE | 5 |
| GUN | GUANINE | 4 |
| MLA | MALONIC ACID | 4 |
| C2X | 9,9'-{(2R,3R,3aR,5S,7aR,9R,10R,10aR,12S,23R,25aR,27R,28R,28aR,30S,32aR,35aR,37S,39aR)-9-(6-amino-9H-purin-9-yl)-34-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-5,12,23,30,37-pentahydroxy-3,10,28-trimethoxy-5,12,23,30,37-pentaoxidotetracosahydro-2H,7H,25H-trifuro[3,2-f:3',2'-l:3'',2''-x]pyrrolo[3,4-r][1,3,5,9,11,15,17,21,23,27,29,2,4,10,16,22,28]undecaoxazapentaphosphacyclopentatriacontine-2,27-diyl}bis(2-amino-3,9-dihydro-6H-purin-6-one) | 3 |
| FMC | (1S)-1-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-D-ribitol | 3 |
| GAL | beta-D-galactopyranose | 3 |
| MY6 | 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one | 3 |
| NCA | NICOTINAMIDE | 3 |
| URA | URACIL | 3 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 2 |
| A1BH2 | 5-(2,6-diethylphenyl)thiophene-2-carboxylic acid | 2 |
| A1BH4 | (5M)-5-(2-ethyl-6-methylphenyl)thiophene-2-carboxylic acid | 2 |
| ADN | ADENOSINE | 2 |